Our Latest Thinking on the Health Care Industry

From regulatory affairs to shop-floor support to tech transfers, the GenAI opportunities for biopharma and medtech companies are real—and growing.

How do companies design a fit-for-purpose model that combines the best attributes of big and small pharma, biotech, venture capital, and tech company approaches?

Persistent underdiagnosis and undertreatment of common conditions have created a massive gap in the health care market for US women.

Leaders should look to leverage their investments in AI as they weigh innovation spending against a renewed focus on cost, says BCG’s Priya Chandran.

The industry’s ability to unlock the next wave of innovation and to continue its strong record of shareholder returns is at risk.

The Team B approach involves assembling an independent cross-functional team to conduct rapid reviews of launch plans and market conditions for new pharmaceutical products.

Biopharma companies can leverage new sources of patient data and technology to create more personalized patient experiences that have the potential to deliver better health outcomes.

Bausch + Lomb CEO Brent Saunders talks about his leadership philosophy and how the company is excelling in such an innovation-focused industry.

The global biopharma company’s chief data and technology officer discusses its initiative to inject digital capabilities across the value chain and the importance of prioritizing patient outcomes.

Mike McDonnell explains how the global biotech is charting new paths to patients via Fit for Growth, its corporate transformation initiative.

Chief Digital and Technology Officer Lidia Fonseca explains how Pfizer is leveraging digital and data across the value chain and the biggest wins so far.

States and payers should consider integrated care models that combine Medicare and Medicaid benefits for dual eligibles to improve outcomes and lower costs.

In the health care industry, women have achieved gender parity at nearly all levels—except CEO. What can be done to break the glass ceiling?

To spur innovation and compete for products in the early ideation phase, companies should set aside funding for acquisitions, licensing, and partnerships, says Baxter's John Ranz.

Payers that outsource their business processes can quickly advance their capabilities to elevate operational efficiency and competitive advantage while reducing costs.

While digital, data, and AI have extraordinary potential to revolutionize our global health care systems, they have yet to deliver a transformative impact. How can the public and private sectors accelerate progress?

A surge in AI-driven medical devices ten years in the making is poised to accelerate further, powered by regulatory evolution, venture capital investment, and the promise of better, more efficient care.

GLP-1 drugs are reshaping chronic disease care. What does that mean for medtech over the next decade?

As the regulatory burden in medtech grows, a structured approach to using generative AI can provide dramatic gains in efficiency, accuracy, and other key metrics.

By developing products for a broader base of patients and markets, medtech companies can improve health outcomes, generate business advantages, and contribute to healthier societies overall.

As the largest employer and controller of capital and supply chains, the private sector is well positioned to set new industry standards and support planetary and human health in the face of climate change. Actions to strengthen food systems, rethink urban infrastructure, improve health care responses, and reshape insurance models will be essential to mitigating risks and building climate resilience.

Extreme weather events such as cyclones and floods will drive increases in the incidence of sickness and death from malaria in Africa, according to a new study.

BCG conducted a study of more than 70 organizations—including philanthropies, multilateral development banks, government agencies, nongovernmental organizations, private sector actors, and others—to understand how key stakeholders are approaching the climate-health challenge.

Too often is it taken for granted that the environment is a massive determinant of human well-being. Putting health at the center of our climate discussions is critical.